GClnc1 was found to be up-regulated in both tissue and circulating EV samples in early-stage GC (stages I and II), with a high area under the curve (AUC) of 0.9369 (95% CI: 0.9073–0.9664). This evidence concerns the gene SOD2 and gastric cancer.